|
ETV6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.18279999817528E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.75100000019557E-07 |
| Normal-vs-Stage2 |
1.115320E-03 |
| Normal-vs-Stage3 |
3.055200E-03 |
| Normal-vs-Stage4 |
2.129000E-01 |
| Stage1-vs-Stage2 |
7.672600E-01 |
| Stage1-vs-Stage3 |
6.663400E-01 |
| Stage1-vs-Stage4 |
1.883350E-01 |
| Stage2-vs-Stage3 |
9.336800E-01 |
| Stage2-vs-Stage4 |
1.974040E-01 |
| Stage3-vs-Stage4 |
2.676000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.773399999771E-07 |
| Normal-vs-AfricanAmerican |
1.59309999999691E-05 |
| Normal-vs-Asian |
4.673800E-01 |
| Caucasian-vs-AfricanAmerican |
7.103800E-01 |
| Caucasian-vs-Asian |
2.468600E-01 |
| AfricanAmerican-vs-Asian |
1.554620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07059999998604E-06 |
| Normal-vs-Female |
2.31080000023809E-07 |
| Male-vs-Female |
7.054100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.040100E-03 |
| Normal-vs-Extreme_Weight |
6.09259999999612E-05 |
| Normal-vs-Obese |
3.12020000003965E-06 |
| Normal-vs-Extreme_Obese |
4.003600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.819400E-01 |
| Normal_Weight-vs-Obese |
4.606000E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.178400E-01 |
| Extreme_Weight-vs-Obese |
6.276200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.286410E-01 |
| Obese-vs-Extreme_Obese |
6.180400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.259200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.0641999977129E-08 |
| Normal-vs-Age(61-80Yrs) |
2.20689999999024E-05 |
| Normal-vs-Age(81-100Yrs) |
3.024600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.230000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.290980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.172300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.009700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.636000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.503620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.54950000502896E-08 |
| Normal-VS-Type2 PRCC |
3.835800E-02 |
| Normal-VS-KIRP CIMP |
5.055800E-03 |
| Normal-VS-Unclassified PRCC |
1.172040E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.005900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.689800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.627600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.235700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.597900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.004600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.745730E-02 |
| Normal-vs-N1 |
3.683700E-03 |
| Normal-vs-N2 |
2.16579998379984E-09 |
| N0-vs-N1 |
1.195830E-01 |
| N0-vs-N2 |
7.52739999998475E-07 |
| N1-vs-N2 |
1.203380E-01 |
|
|
